Safe Food Practices at Home for Immunocompromised Patients With Cancer

September 30th 2025, 9:00pm

By Heather Ann Yonker

Heather Ann Yonker expands on strategies for maintaining food safety in the home, particularly for patients with compromised immune systems due to cancer.

Positive Experience With TAR-200 for Recurrent Bladder Cancer

September 30th 2025, 8:00pm

By Frank Garred

Frank Garred, 77, completed Inlexzo treatment for recurrent bladder cancer, describing it as manageable with minimal side effects compared with BCG.

Acupressure May Relieve Nausea, Vomiting for Patients With Cancer

September 30th 2025, 7:00pm

By Alex Biese

For patients with cancer grappling with nausea or vomiting due to their treatments, a potential side effect remedy may be found in their own hands.

I No Longer Think About Cancer Every Day

September 30th 2025, 5:00pm

By Mary Sansone

New Strategy May Prevent Breast Cancer Relapse

September 30th 2025, 4:00pm

By Spencer Feldman

Penn Medicine researchers found two oral drugs eliminated dormant breast cancer cells in most patients, with relapse rates dropping to about 4% after seven years.

Mytesi Seeks FDA Orphan Drug Designation in Breast Cancer Diarrhea

September 30th 2025, 3:00pm

By Alex Biese

Napo Pharmaceuticals applied for orphan drug designation for Mytesi to treat diarrhea in patients with breast cancer and brain metastases on targeted therapy.

Combination Therapies May Improve Survival in EGFR+ Lung Cancer

September 30th 2025, 1:00pm

By Dr. Edgardo Santos

Dr. Edgardo Santos explains that combining Tagrisso with chemotherapy or Leclaza plus Rybrevant may improve survival versus monotherapy alone.

Photobiomodulation Device Cuts Oral Mucositis in Head and Neck Cancer

September 29th 2025, 9:00pm

By Bridget Hoyt

An LED-based intraoral device was safe and reduced severe oral mucositis and throat pain in patients receiving radiotherapy for head and neck cancers.

The Importance of Awareness and Self-Advocacy in Multiple Myeloma

September 29th 2025, 8:00pm

By Ryan Scott

Tamara Mobley shares how persistent back pain led to her myeloma diagnosis and why she now raises awareness to help others recognize subtle warning signs.

Why Multidisciplinary Care is Crucial in Prostate Cancer

September 29th 2025, 7:00pm

By Dr. Kai Tsao

Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary team of healthcare providers.

How Testicular Cancer Taught Me to Be True to Myself

September 29th 2025, 5:00pm

By Brian Sluga

After surviving testicular cancer, I learned to let go of envy, live in the moment, and embrace gratitude by staying true to who I am.

Real-World vs Clinical Trial Biomarker Testing in Early-Stage NSCLC

September 29th 2025, 4:00pm

By Dr. Sandip Patel

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.

Enhertu Improves Invasive Disease-Free Survival in HER2+ Early Breast Cancer

September 29th 2025, 3:00pm

By Alex Biese

Enhertu significantly improved invasive disease-free survival when compared with Kadcyla in high-risk HER2-positive early breast cancer.

How Individual Risk Factors May Guide Bladder Cancer Treatment

September 29th 2025, 1:00pm

By Dr. Patrick J. Hensley

Dr. Patrick J. Hensley shares the treatment landscape of non-muscle-invasive bladder, as well as how individual risk factors can alter treatment options.

How FDA-Approved Modeyso Works to Treat Glioma

September 28th 2025, 6:00pm

By Dr. Patrick Wen

Dr. Patrick Wen discussed with CURE how Modeyso treats diffuse midline glioma, and what unmet needs remain for patients now that the therapy is available.